| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹451.25 Cr |
| Fresh Issue | ₹175.00 Cr |
| Offer for Sale | ₹276.25 Cr |
| Face Value | โน2 Per Equity Share |
| Price Band | โน309.00-325.00 per share |
| BSE Code | 544491 |
| NSE Code | GEMAROMA |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Motilal Oswal Investment Advisors... |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 46 shares and in multiples thereof
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India, with over two decades of experience. The company offers various products, from Mother Ingredients to Value-Added Derivatives.
The company's products are used in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain management, and personal care.
The company provides a total of seventy products, categorized into four distinct groups, which include:
In Fiscal 2025, the company serves 225 customers and 44 international customers across 18 countries, including the Americas, Asia, Africa, and Australia.
The company sells products directly to customers on a business-to-business basis, with export sales through methods including (i) direct sales, (ii) sales via its subsidiary, Gem Aromatics LLC, in the USA, and (iii) sales through third-party agencies.
As of Mar 31, 2025, the company had an in-house R&D team of 13 scientists who pivotally implemented state-of-the-art technology that advanced our formulations in Value-Added Derivatives.
Competitive Strength
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by Company and Subsidiary, Krystal Ingredients Pvt.Ltd. | 140.00 |
| 2 | General Corporate Purposes | 22.86 |
| 3 | Issue Expenses | 31.27 |
| Total | 194.14 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 534.52 | 368.57 | 295.76 |
| Total Income | 505.64 | 454.23 | 425.09 |
| Profit After Tax | 53.38 | 50.10 | 44.67 |
| EBITDA | 88.45 | 78.35 | 66.19 |
| NET Worth | 283.98 | 230.55 | 179.53 |
| Reserves and Surplus | 278.26 | 224.88 | 182.36 |
| Total Borrowing | 222.37 | 111.13 | 89.36 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 18.80% |
| ROCE | 16.02% |
| Debt / Equity | 0.78% |
| RoNW | 18.80% |
| PAT Margin | 10.56% |
| EBITDA Margin | 17.55% |
| Price to Book Value | 5.36 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 11.39 | 10.22 |
| P/E (x) | 28.52 | 31.8 |
| Promoter Holding | 75% | 55.06% |
| Market Cap | โน1697.71 Cr. | |